1296271-15-2

Upstream product

• 99-76-3 methyl 4-hydroxylbenzoate 
• 1296271-51-6 8-(1-((3,5-difluorophenyl)(methyl)amino)ethyl)-2-morpholino-4-oxo-4H-chromene-6-carboxylic acid 
• 29415-97-2 methyl 3-bromo-4-hydroxybenzoate 
• 149817-68-5 methyl 4-acetoxy-3-bromobenzoate 
• 109-83-1 (2-hydroxyethyl)(methyl)amine 
• 1296271-38-9 methyl 3-bromo-4-hydroxy-5-(3-morpholino-3-oxopropanoyl)benzoate 
• 62604-08-4 4-morpholinecarbodithioic acid methyl ester 
• 71407-98-2 3-acetyl-5-bromo-4-hydroxybenzoic acid 
• 1296271-33-4 methyl 8-bromo-2-morpholino-4-oxo-4H-chromene-6-carboxylate 
• 57009-12-8 methyl 3-acetyl-4-hydroxybenzoate 
• 160753-84-4 methyl 3-acetyl-5-bromo-4-hydroxybenzoate 
• 52631-31-9 4-(dichloromethylene)morpholin-4-ium chloride 
• 1296272-06-4 methyl 8-(1-((3,5-difluorophenyl)(methyl)amino)ethyl)-2-morpholino-4-oxo-4H-chromene-6-carboxylate 
• 1296271-41-4 methyl 8-(1-bromoethyl)-2-morpholino-4-oxo-4H-chromene-6-carboxylate 

Relevant academic research and scientific papers

CHROMENONE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY

The invention concerns chromenone derivatives of Formula (I) or a pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, n and R9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.

CHROMENONE DERIVATIVES

The invention concerns chromenone derivatives of Formula I or a pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, n and R9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.